Project Grant HT94252310932

The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,416,000 Project Grant to The Children's Hospital Corporation (Boston Children's Hospital), a non-profit teaching hospital and research center affiliated with Harvard Medical School. The grant, titled "IND-ENABLING STUDIES OF POLYMERASE INHIBITORS FOR BMF DUE TO TELOMERE EXHAUSTION", will support a 2-year research project from Sep 1, 2023 to Aug 31, 2025. Through this funding, Boston Children's Hospital will conduct preclinical studies to investigate investigational new drug candidates for the treatment of bone marrow failure due to telomere dysfunction. The hospital has significant experience delivering a range of services under federal grants and contracts, including clinical trial management, data collection, and collaborative research with universities and government agencies like NIH and DoD.